知镜 Cognispect · 医学文献与研究工作台

Larger Non-metastatic No. 8 Lymph Node Size Is Associated With Favorable Prognosis After Pancreaticoduodenectomy for Pancreatic Cancer

Sakamoto T, Gocho T, Tsunematsu M, et al.
Cancer Diagn Progn · 2026-11-01 · PMID 42968953

文献摘要

Background/aim Although lymph node metastasis is a negative prognostic factor in pancreatic cancer, the significance of non-metastatic lymph node enlargement remains unclear. This study evaluated the prognostic impact of the No. 8 lymph node (N8LN), which is routinely assessed during pancreaticoduodenectomy and identifiable on preoperative imaging. Patients and methods We retrospectively reviewed 99 patients who underwent pancreaticoduodenectomy for pancreatic cancer between 2009 and 2019. The size of the N8LN was measured on preoperative imaging, and patients were divided into small and large groups based on the median value. Long-term oncologic outcomes were compared between the two groups. To assess the local immune response, CD8 immunohistochemistry was performed on nodal sections, and CD8⁺ T-cell density was quantified using QuPath software. Results The large group showed significantly longer progression-free survival (19.7 vs . 9.4 months) and disease-specific survival (41.7 vs . 17.1 months) than the small group. Enlarged N8LN remained an independent favorable prognostic factor in multivariable analysis. CD8⁺ T-cell density did not differ between groups. Conclusion Enlarged N8LN size was independently associated with better survival after pancreaticoduodenectomy. Nodal enlargement may reflect host immune activity rather than tumor progression and merits further investigation.

在知镜精读原文来源DOI 原文

知镜提供医学文献检索、阅读笔记、人体图谱、统计绘图与研究复现工具。